Table of Content

1. Introduction
1.1. Product Definition
1.2. Research Process
1.3. Glossary
1.4. Market Segmentation

2. Executive Summary

3. Expert Verbatim- Interview Excerpts of 10 industry experts

4. Impact of COVID-19 on Global Biologics Market

5. Global Biologics Market Outlook, 2016-2026F
5.1. Market Size & Analysis
5.1.1. By Revenue
5.2. Market Share & Analysis
5.2.1. By Therapeutic Application
5.2.1.1. Oncology
5.2.1.2. Infectious Disease
5.2.1.3. Autoimmune Disease
5.2.1.4. Diabetes
5.2.1.5. Metabolic disorders
5.2.1.6. Inflammatory Bowel Diseases
5.2.1.7. Respiratory Disorders
5.2.1.8. Neurological Disorders
5.2.1.9. Cardiovascular Disorder
5.2.1.10. Musculoskeletal Disorders
5.2.1.11. Ophthalmic Disorders
5.2.1.12. Others
5.2.2. By Distribution channel
5.2.2.1. Hospital Pharmacies
5.2.2.2. Retail Pharmacies
5.2.2.3. Online Pharmacies
5.2.3. By Manufacturing
5.2.3.1. Outsource
5.2.3.2. In-house
5.2.4. By Product/Drug Class
5.2.4.1. Recombinant therapeutic Products
5.2.4.1.1. Monoclonal Antibodies
5.2.4.1.2. Hormones
5.2.4.1.3. Cytokines
5.2.4.1.4. Enzymes
5.2.4.2. Blood and Blood Components
5.2.4.3. Cellular and Gene Therapy
5.2.4.4. Vaccines
5.2.4.5. Oligonucleotides
5.2.5. By Region
5.2.5.1. North America
5.2.5.2. South America
5.2.5.3. Europe
5.2.5.4. Asia-Pacific
5.2.5.5. Middle East & Africa
5.2.6. By Company
5.2.6.1. Revenue Shares
5.2.6.2. Strategic Factorial Indexing
5.2.6.3. Competitor Placement in MarkNtel Quadrant

6. North America Biologics Market Outlook, 2016-2026F
6.1. Market Size & Analysis
6.1.1. By Revenue
6.2. Market Share & Analysis
6.2.1. By Therapeutic application
6.2.2. By Distribution Channel
6.2.3. By Manufacturing
6.2.4. By Product/Drug Class
6.2.5. By Country
6.2.5.1. US
6.2.5.2. Canada
6.2.5.3. Mexico
6.3. US Biologics Market Outlook, 2016-2026F
6.3.1. Market Size & Analysis
6.3.1.1. By Revenue
6.3.2. Market Share & Analysis
6.3.2.1. By Therapeutic application
6.3.2.2. By Distribution Channel
6.3.2.3. By Manufacturing
6.3.2.4. By Product/Drug Class
6.4. Canada Biologics Market Outlook, 2016-2026F
6.4.1. Market Size & Analysis
6.4.1.1. By Revenue
6.4.2. Market Share & Analysis
6.4.2.1. By Therapeutic application
6.4.2.2. By Distribution Channel
6.4.2.3. By Manufacturing
6.4.2.4. By Product/Drug Class
6.5. Mexico Biologics Market Outlook, 2016-2026F
6.5.1. Market Size & Analysis
6.5.1.1. By Revenue
6.5.2. Market Share & Analysis
6.5.2.1. By Therapeutic application
6.5.2.2. By Distribution Channel
6.5.2.3. By Manufacturing
6.5.2.4. By Product/Drug Class

7. South America Biologics Market Outlook, 2016-2026F
7.1. Market Size & Analysis
7.1.1. By Revenue
7.2. Market Share & Analysis
7.2.1. By Therapeutic application
7.2.2. By Distribution Channel
7.2.3. By Manufacturing
7.2.4. By Product/Drug Class
7.2.5. By Country
7.2.5.1. Brazil
7.2.5.2. Argentina
7.2.5.3. Others
7.3. Brazil Biologics Market Outlook, 2016-2026F
7.3.1. Market Size & Analysis
7.3.1.1. By Revenue
7.3.2. Market Share & Analysis
7.3.2.1. By Therapeutic application
7.3.2.2. By Distribution Channel
7.3.2.3. By Manufacturing
7.3.2.4. By Product/Drug Class
7.4. Argentina Biologics Market Outlook, 2016-2026F
7.4.1. Market Size & Analysis
7.4.1.1. By Revenue
7.4.2. Market Share & Analysis
7.4.2.1. By Therapeutic application
7.4.2.2. By Distribution Channel
7.4.2.3. By Manufacturing
7.4.2.4. By Product/Drug Class

8. Europe Biologics Market Outlook, 2016-2026F
8.1. Market Size & Analysis
8.1.1. By Revenue
8.2. Market Share & Analysis
8.2.1. By Therapeutic application
8.2.2. By Distribution Channel
8.2.3. By Manufacturing
8.2.4. By Product/Drug Class
8.2.5. By Country
8.2.5.1. The UK
8.2.5.2. Germany
8.2.5.3. France
8.2.5.4. Italy
8.2.5.5. Spain
8.2.5.6. Others
8.3. UK Biologics Market Outlook, 2016-2026F
8.3.1. Market Size & Analysis
8.3.1.1. By Revenue
8.3.2. Market Share & Analysis
8.3.2.1. By Therapeutic application
8.3.2.2. By Distribution Channel
8.3.2.3. By Manufacturing
8.3.2.4. By Product/Drug Class
8.4. Germany Biologics Market Outlook, 2016-2026F
8.4.1. Market Size & Analysis
8.4.1.1. By Revenue
8.4.2. Market Share & Analysis
8.4.2.1. By Therapeutic application
8.4.2.2. By Distribution Channel
8.4.2.3. By Manufacturing
8.4.2.4. By Product/Drug Class
8.5. France Biologics Market Outlook, 2016-2026F
8.5.1. Market Size & Analysis
8.5.1.1. By Revenue
8.5.2. Market Share & Analysis
8.5.2.1. By Therapeutic application
8.5.2.2. By Distribution Channel
8.5.2.3. By Manufacturing
8.5.2.4. By Product/Drug Class
8.6. Italy Biologics Market Outlook, 2016-2026F
8.6.1. Market Size & Analysis
8.6.1.1. By Revenue
8.6.2. Market Share & Analysis
8.6.2.1. By Therapeutic application
8.6.2.2. By Distribution Channel
8.6.2.3. By Manufacturing
8.6.2.4. By Product/Drug Class
8.7. Spain Biologics Market Outlook, 2016-2026F
8.7.1. Market Size & Analysis
8.7.1.1. By Revenue
8.7.2. Market Share & Analysis
8.7.2.1. By Therapeutic application
8.7.2.2. By Distribution Channel
8.7.2.3. By Manufacturing
8.7.2.4. By Product/Drug Class

9. Asia-Pacific Biologics Market Outlook, 2016-2026F
9.1. Market Size & Analysis
9.1.1. By Revenue

10. Market Share & Analysis
10.1. By Therapeutic application
10.2. By Distribution Channel
10.3. By Manufacturing
10.4. By Product/Drug Class
10.5. By Country
10.5.1. China
10.5.2. India
10.5.3. Japan
10.5.4. Australia
10.5.5. South Korea
10.5.6. Others

11. China Biologics Market Outlook, 2016-2026F
11.1. Market Size & Analysis
11.1.1. By Revenue
11.2. Market Share & Analysis
11.2.1. By Therapeutic application
11.2.2. By Distribution Channel
11.2.3. By Manufacturing
11.2.4. By Product/Drug Class

12. India Biologics Market Outlook, 2016-2026F
12.1. Market Size & Analysis
12.1.1. By Revenue
12.2. Market Share & Analysis
12.2.1. By Therapeutic application
12.2.2. By Distribution Channel
12.2.3. By Manufacturing
12.2.4. By Product/Drug Class
13. Japan Biologics Market Outlook, 2016-2026F
13.1. Market Size & Analysis
13.1.1. By Revenue
13.2. Market Share & Analysis
13.2.1. By Therapeutic application
13.2.2. By Distribution Channel
13.2.3. By Manufacturing
13.2.4. By Product/Drug Class
14. Australia Biologics Market Outlook, 2016-2026F
14.1. Market Size & Analysis
14.1.1. By Revenue
14.2. Market Share & Analysis
14.2.1. By Therapeutic application
14.2.2. By Distribution Channel
14.2.3. By Manufacturing
14.2.4. By Product/Drug Class
15. South Korea Biologics Market Outlook, 2016-2026F
15.1. Market Size & Analysis
15.1.1. By Revenue
15.2. Market Share & Analysis
15.2.1. By Therapeutic application
15.2.2. By Distribution Channel
15.2.3. By Manufacturing
15.2.4. By Product/Drug Class
16. Middle East and Africa Biologics Market Outlook, 2016-2026F
16.1. Market Size & Analysis
16.1.1. By Revenue
16.2. Market Share & Analysis
16.2.1. By Therapeutic application
16.2.2. By Distribution Channel
16.2.3. By Manufacturing
16.2.4. By Product/Drug Class
16.2.5. By Country
16.2.5.1. UAE
16.2.5.2. Saudi Arabia
16.2.5.3. Others
17. UAE Biologics Market Outlook, 2016-2026F
17.1. Market Size & Analysis
17.1.1. By Revenue
17.2. Market Share & Analysis
17.2.1. By Therapeutic application
17.2.2. By Distribution Channel
17.2.3. By Manufacturing
17.2.4. By Product/Drug Class
18. Saudi Arabia Biologics Market Outlook, 2016-2026F
18.1. Market Size & Analysis
18.1.1. By Revenue
18.2. Market Share & Analysis
18.2.1. By Therapeutic application
18.2.2. By Distribution Channel
18.2.3. By Manufacturing
18.2.4. By Product/Drug Class
19. Global Biologics Dynamics
19.1. Drivers
19.2. Challenges
19.3. Impact Analysis
20. Global Biologics Regulations, Product Standards
21. Global Biologics Intellectual Property Rights Analysis
22. Global Biologics Hotspots & Opportunities
23. Competition Outlook
23.1. Competitor Wise Growth Strategies
23.1.1. Product Portfolio
23.1.2. Brand Specialization
23.1.3. Target Markets
23.1.4. Research & Development
23.1.5. Strategic Alliances & Initiatives
23.2. Company Profiles
23.2.1. Abbive Inc.
23.2.2. Amgen Inc.
23.2.3. F. Hoffman La Roche
23.2.4. Samsung Electronics
23.2.5. Merck & Co.
23.2.6. AstraZenca Plc.
23.2.7. Bristol-Myers Squibb
23.2.8. Novartis
23.2.9. Pfizer
23.2.10. Sanofi
24. Disclaimer